Navigation Links
New Study from AAN: Herpes May Lead to Alzheimer’s Disease; polyDNA Recommends Gene-Eden-VIR Against the Herpes Virus
Date:4/12/2013

Rochester, NY (PRWEB) April 12, 2013

A new study “links a form of the ApoE gene known as ApoE-4, which after advanced age is the leading known risk factor for getting Alzheimer's disease, with the form of herpes – herpes simplex 1 or HSV – that infects more than 80 percent of Americans and causes cold sores around the mouth.” (1)

Another study has found that “people who have had higher levels of infection in their blood (measured by antibody levels), meaning they had been exposed over the years to various pathogens such as the herpes simplex type 1 virus that causes cold sores, were more likely to have cognitive problems than people with lower levels of infection in the blood.” (2)

Mira Katan, MD said that treatments “…against viruses could decrease the risk for memory problems later in life.”

"The key to your health is to reduce the level of the chronic viruses in your body to harmless levels." - Dr. Hanan Polansky

The public should be aware of the fact that herpes could lead to Alzheimer’s disease over time. polyDNA recommends that people educate themselves about Gene-Eden-VIR, a natural remedy against the latent herpes virus.

By helping the body’s immune system target the latent herpes virus, people also lower their risk of developing fever blisters, cold sores, genital herpes symptoms, and may also help prevent Alzheimer’s disease.

In a post marketing clinical study, Gene-Eden-VIR was shown to be safe and highly effective against the latent herpes virus. Over 70% of Gene-Eden-VIR users reported a reduction in herpes symptoms. (3)

Each capsule of Gene-Eden-VIR contains a patented formula of five all natural ingredients including selenium, camellia sinesis extract, quercetin, cinnamomum extract, and licorice extract. In addition, each bottle is GMP Certified. (4)

To learn more about Gene-Eden-VIR, the only product on the market today that helps the body target the latent herpes virus and that is scientifically backed by published material, visit http://www.gene-eden-kill-virus.com.

Reference:

(1) http://www.eurekalert.org/pub_releases/2007-01/uorm-csv010307.php

(2) http://www.aan.com/press/index.cfm?fuseaction=release.view&release=1168

(3) http://www.cbcd.net/Gene-Eden-VIR-Clinical-Study.php

(4) http://www.gene-eden-kill-virus.com/studies.php
###

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA.

The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases. polyDNA developed Gene-Eden-VIR (), an antiviral natural remedy that helps the immune system kill latent viruses.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10623861.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Stanford study shows different brains have similar responses to music
2. Treating Sleep Apnea Pays Off at Work, Study Finds
3. Study Links Stillbirth to Genes Tied to Dangerous Heart Rhythm
4. Older people may be at greater risk for alcohol impairment than teens, according to Baylor Study
5. Study reports adenoma detection rates are higher than current guidelines suggest in both men and women
6. Study Puts New Spin on Sound Sleep
7. Gulp! Study Suggests Super-Size Soda Ban Could Fizzle
8. Physician-Assisted Suicide Program Rarely Used, Study Finds
9. Gauging Brain Cancer Survival Time May Get Easier: Study
10. Study Hints of Links Between HPV and Lung Cancer
11. Study suggests federal guidelines for treating teen PID need clarification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... entered a settlement agreement to resolve the pending litigation between itself and 1800 ... the District of Utah). , “I am thrilled to announce that we have ...
(Date:3/27/2017)... ... March 27, 2017 , ... From 1999 ... alone responsible for over 33,000 of the 52,404 drug-related deaths in 2015.(2) To ... 1512, which proposes a tax on prescription opioids to fund drug rehabilitation and ...
(Date:3/27/2017)... ... March 27, 2017 , ... Harris Communications, Inc., a leading provider of ... products to the Deaf Seniors of America Conference, April 4-7 at the Hotel Westin ... knowledgeable ASL friendly staff from Harris Communications and to try out the newest assistive ...
(Date:3/25/2017)... Square, PA (PRWEB) , ... March 25, 2017 , ... ... priority as a public relations partner. , All through the year, Garden Media ... and press releases, working with key influencers and pitching client’s key messages ...
(Date:3/24/2017)... ... March 24, 2017 , ... Clean Earth, ... material, and hazardous and non-hazardous materials announced today the acquisition of privately owned ... will add four additional processing facilities and a vast array of additional technologies, ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Research and Markets has announced the addition of ... their offering. ... The Cell Therapy Manufacturing Market, 2017-2027 report provides an ... manufacturing and focuses both on contract manufacturers and cell therapy ... emerge as viable alternatives to conventional treatment options. ...
(Date:3/24/2017)... PUNE, India , March 24, 2017 According ... Market: Global Opportunity Analysis and Industry Forecast, 2014-2022," the spine bone stimulators market ... million by 2022, growing at a CAGR of 3.6% during the forecast period. ... ... Allied Market Research Logo ...
(Date:3/24/2017)... Calif. , March 24, 2017 /PRNewswire/ ... epigenetics company, and Hamilton Robotics, Inc., who ... announced an ongoing collaboration that teams Zymo ... and RNA and DNA extraction products with ... already created optimized methods for microbiomics and ...
Breaking Medicine Technology: